In ₹ Crore except Per Share Latest Annual	KRSNAA FY26	SURAKSHA FY26	HEALTHX FY26	NEPHROPLUS FY26	Peer Average
Valuation — at last close
P/E	◆ 15.91×	51.71×	754.59×	74.12×	293.47× -95%
P/B	1.65×	6.80×	◆ 1.39×	5.65×	4.61× -64%
EV/EBITDA	8.44×	17.17×	◆ -19.27×	26.26×	8.05× +5%
Market Cap	₹1,615 Cr	₹1,664 Cr	₹888 Cr	₹6,307 Cr	₹2,953 Cr -45%
Growth
Revenue CAGR 3Y	◆ 16.63%	—	8.26%	—	8.26% +101%
Revenue CAGR 5Y	—	—	19.20%	—	19.20%
Net Income CAGR 3Y	17.76%	—	—	—	—
Revenue YoY (latest Q)	22.05%	20.75%	◆ 49.73%	—	35.24% -37%
Net Income YoY (latest Q)	-19.34%	◆ 40.00%	-92.53%	—	-26.27% +26%
Profitability
EBITDA Margin	27.42%	◆ 30.73%	-3.95%	22.72%	16.50% +66%
Net Income Margin	◆ 13.13%	10.12%	-0.11%	7.69%	5.90% +123%
Return on Common Equity	10.89%	◆ 14.11%	0.18%	6.88%	7.06% +54%
Return on Capital Employed	9.62%	◆ 15.88%	—	11.63%	13.76% -30%
Return on Assets	6.53%	◆ 8.04%	-0.15%	5.22%	4.37% +49%
Credit & Quality
Total Debt/Equity	0.55×	◆ 0.01×	0.03×	0.07×	0.04× +1400%
Interest Coverage	3.53×	◆ 4.30×	-75.12×	2.26×	-22.85× +115%
Scale — latest FY
Revenue / Total Income	₹773 Cr	₹310 Cr	₹1,319 Cr	₹999 Cr	₹876 Cr -12%
Net Income	₹101 Cr	₹31.4 Cr	−₹1.4 Cr	₹76.8 Cr	₹35.6 Cr +185%
Total Assets	₹1,824 Cr	₹448 Cr	₹936 Cr	₹1,471 Cr	₹952 Cr +92%
EPS	₹31.3	₹6.18	₹0.37	₹8.48	₹5.01 +525%
Book Value per Share	₹302.23	₹47.01	₹201.47	₹111.27	₹119.92 +152%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.